An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Clinical Review Report: Apomorphine (Movapo): (Paladin Labs Inc.): Indication: The acute, intermittent treatment of hypomobility “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) in patients with advanced Parkinson’s disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Feb.
Top results in this bookTable of Contents
Clinical Review Report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo): (Purdue Pharma): Indication: In combination with dexamethasone, once-per-cycle treatment for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, or with moderately emetogenic cancer chemotherapy that is uncontrolled by a 5-hydroxytryptamine-3 receptor antagonist alone [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jun.
Pharmacoeconomic Review Report: Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo): (Purdue Pharma): Indication: In combination with dexamethasone, once-per-cycle treatment for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, or with moderately emetogenic cancer chemotherapy that is uncontrolled by a 5-HT3 receptor antagonist alone [Internet].
Pharmacoeconomic Review Report: Apomorphine (Movapo): (Paladin Labs Inc.): Indication: The acute, intermittent treatment of hypomobility “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) in patients with advanced Parkinson’s disease [Internet].
CADTH Canadian Drug Expert Committee Recommendation: Apomorphine Hydrochloride (Movapo — Paladin Labs Inc.): Indication: Parkinson’s disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jan.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Polycyclic Aromatic Hydrocarbons: Evaluation of Sources and Effects.
National Research Council (US) Committee on Pyrene and Selected Analogues.
Washington (DC): National Academies Press (US); 1983.
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Styrene, Styrene-7,8-oxide, and Quinoline.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
Lyon (FR): International Agency for Research on Cancer; 2019. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 121.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on